ACAD
31.32
-0.39
-1.21%
AEMD
0.25
0.00
-1.19%
APRI
1.34
+0.12
+9.84%
ARNA
4.56
-0.21
-4.40%
ATEC
1.29
-0.03
-2.27%
CFN
59.54
-0.2
-0.33%
CNAT
5.79
-0.31
-5.05%
CRXM
0.21
+0.01
+6.01%
CYTX
0.48
-0.02
-3.37%
DXCM
60.57
-1.75
-2.81%
GNMK
13.06
-0.45
-3.33%
HALO
14.18
-0.3
-2.07%
ILMN
198.41
-4.84
-2.38%
INNV
0.2
+0.00
+0.05%
INO
8.5
-0.44
-4.92%
ISCO
0.06
0.00
-4.17%
ISIS
69.07
-3.33
-4.60%
LGND
57.32
-1.25
-2.13%
LPTN
2.89
-0.05
-1.70%
MBVX
1.15
+0.04
+3.60%
MEIP
3.69
0.00
0.00%
MNOV
3.74
+0.28
+8.09%
MRTX
20.34
-0.64
-3.05%
MSTX
0.45
0.00
-0.55%
NBIX
33.43
-0.11
-0.33%
NUVA
46.48
-0.45
-0.96%
ONCS
0.39
-0.01
-2.41%
ONVO
6.47
-0.12
-1.82%
OREX
5.49
-0.19
-3.26%
OTIC
31.54
-2.88
-8.37%
QDEL
24.3
-0.66
-2.64%
RCPT
113.22
-3.47
-2.97%
RGLS
17.47
-1.43
-7.57%
RMD
63.26
-1.94
-2.98%
SCIE
0.01
+0.00
+5.04%
SPHS
0.45
-0.04
-7.90%
SRNE
10.25
-0.37
-3.47%
TROV
5.82
-0.13
-2.12%
VICL
1.04
+0.01
+0.49%
VOLC
17.95
-0.02
-0.11%
ZGNX
1.35
-0.04
-2.75%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.